» Articles » PMID: 28326080

Characterization of the Highly Prevalent Regulatory CD24CD38 B-Cell Population in Human Cord Blood

Overview
Journal Front Immunol
Date 2017 Mar 23
PMID 28326080
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The newborn's immune system must transition from a sterile haploidentical uterus to the world full of antigens. Regulatory B-cells (Breg; broadly defined as CD19CD24CD38) are tolerance promoters in the adult immune system. They can inhibit IFN-γ and IL-17 production by T-cells and are essential in different conditions, including pregnancy. Breg have still not been well characterized in umbilical cord blood, where we hypothesize that they are pivotal in the achievement of tolerance. We studied CD19CD24CD38 Breg in healthy umbilical cord blood (hUCB) compared to healthy peripheral adult blood (hAPB). Total numbers of Breg were increased in hUCB compared to hAPB (34.39 vs. 9.49%;  = 0.0002), especially in the marginal zone-like B-cell subset, in which the most marked difference could be observed between hUCB and hAPB (60.80 vs. 4.94%;  = 0.1). CD24CD38 subset in hUCB produced IL-10 and inhibited T-cell IFN-γ [1.63 vs. 0.95 stimulation ratio (SR);  = 0.004] and IL-4 (1.63 vs. 1.44 SR;  = 0.39) production. Phenotypically, hUCB Breg cells presented IgMIgDCD5CD10CD27 markers, similar to those described in hAPB Breg cells, but they showed increased IgM concentration and decreased expression of CD22 and CD73 markers. Our work characterized the frequency, phenotype, and function of Breg in hUCB, which may contribute to understanding of immune tolerance during pregnancy, paving the way to a new approach to immune-related diseases in the fetus and the newborn.

Citing Articles

B cells: roles in physiology and pathology of pregnancy.

Liu J, Zeng Q, Duan Y, Yeung W, Li R, Ng E Front Immunol. 2024; 15:1456171.

PMID: 39434884 PMC: 11491347. DOI: 10.3389/fimmu.2024.1456171.


Changes in Treg and Breg cells in a healthy pediatric population.

Luo Y, Acevedo D, Vlagea A, Codina A, Garcia-Garcia A, Deya-Martinez A Front Immunol. 2023; 14:1283981.

PMID: 38077340 PMC: 10704817. DOI: 10.3389/fimmu.2023.1283981.


B cell receptor-induced IL-10 production from neonatal mouse CD19CD43 cells depends on STAT5-mediated IL-6 secretion.

Sakai J, Yang J, Chou C, Wu W, Akkoyunlu M Elife. 2023; 12.

PMID: 36735294 PMC: 9934864. DOI: 10.7554/eLife.83561.


The adaptive immune system in early life: The shift makes it count.

Pieren D, Boer M, Wit J Front Immunol. 2022; 13:1031924.

PMID: 36466865 PMC: 9712958. DOI: 10.3389/fimmu.2022.1031924.


Peripheral CD5+ CD10+ B-cell proliferation with atypical morphology attributable to human herpesvirus 6 infection following umbilical cord blood transplantation.

Canali A, Rieu J, Bain B Am J Hematol. 2022; 97(11):1489-1490.

PMID: 35802798 PMC: 9795973. DOI: 10.1002/ajh.26655.


References
1.
Chen Q, Zhu X, Chen R, Liu J, Liu P, Hu A . Early Pregnancy Factor Enhances the Generation and Function of CD4CD25 Regulatory T Cells. Tohoku J Exp Med. 2016; 240(3):215-220. DOI: 10.1620/tjem.240.215. View

2.
Schatorje E, Gemen E, Driessen G, Leuvenink J, van Hout R, de Vries E . Paediatric reference values for the peripheral T cell compartment. Scand J Immunol. 2012; 75(4):436-44. DOI: 10.1111/j.1365-3083.2012.02671.x. View

3.
Blair P, Norena L, Flores-Borja F, Rawlings D, Isenberg D, Ehrenstein M . CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity. 2010; 32(1):129-40. DOI: 10.1016/j.immuni.2009.11.009. View

4.
Sarvaria A, Basar R, Mehta R, Shaim H, Muftuoglu M, Khoder A . IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation. Blood. 2016; 128(10):1346-61. PMC: 5016705. DOI: 10.1182/blood-2016-01-695122. View

5.
Mauri C, Ehrenstein M . The 'short' history of regulatory B cells. Trends Immunol. 2008; 29(1):34-40. DOI: 10.1016/j.it.2007.10.004. View